Connect with us

Business

Schweiger Dermatology Group Enhances Access with Same-Week Appointments

Editorial

Published

on

Schweiger Dermatology Group has announced significant advancements in dermatology care by introducing same-week appointments and enhancing its skin cancer treatment services. In 2025, the organization recorded over 2.5 million patient visits, marking a pivotal year in its commitment to patient accessibility and clinical excellence.

Founded in 2010 by board-certified dermatologist Dr. Eric Schweiger, the practice has grown into one of the largest and most comprehensive dermatology groups in the United States. The organization’s mission centers on providing the Ultimate Patient Experience, emphasizing easy access, high-quality care, and compassion. This focus has enabled Schweiger Dermatology to eliminate long waiting times, allowing patients to receive prompt evaluations for various dermatological needs, including medical, cosmetic, and surgical treatments.

Addressing Rising Demand for Early Skin Cancer Detection

Skin cancer remains the most prevalent cancer in the United States. Early detection is vital for effective treatment. According to Dr. Schweiger, “Skin cancer is the most common cancer in the United States, and early detection saves lives. Our priority has always been to get patients seen quickly, treated promptly, and cared for with the highest clinical excellence.”

The organization offers comprehensive full-body skin examinations designed to identify suspicious lesions in their early stages, often when they are most treatable.

Leading the Way in Skin Cancer Treatment

In addition to improving access, Schweiger Dermatology Group has solidified its leadership in advanced skin cancer treatments, performing over 36,000 Mohs surgeries in 2025. This positions the group among the largest providers of Mohs care in the country. Treatments include Mohs micrographic surgery conducted by fellowship-trained Mohs surgeons, surgical excisions, and minimally invasive removal techniques.

Dr. Glen Crawford, Chief Medical Officer, stated, “Dermatology delivers its greatest impact when patients can access it quickly, and that is where Schweiger Dermatology truly stands apart. By expanding both our clinical capabilities and our capacity to see patients sooner, we ease discomfort, reduce anxiety, and enable earlier diagnosis of skin cancers and other serious conditions.”

The practice is committed to a patient-centered model characterized by accessibility, timely communication, and exceptional outcomes. More than 70 board-certified dermatologists at Schweiger Dermatology Group have been recognized as Castle Connolly Top Doctors, reflecting the practice’s commitment to clinical excellence.

Patient satisfaction remains high, with over 90% of patients rating their experience at four or five stars. This year, the organization’s accomplishments were highlighted by its inclusion in the 2025 Crain’s Largest Private Companies in the New York Area list and its ninth consecutive year on the Inc. 5000 List of Fastest Growing Companies in America.

Schweiger Dermatology Group continues to set a standard in the dermatological field, making expert skin care accessible with appointments often available within days. For more information, visit schweigerderm.com.

Our Editorial team doesn’t just report the news—we live it. Backed by years of frontline experience, we hunt down the facts, verify them to the letter, and deliver the stories that shape our world. Fueled by integrity and a keen eye for nuance, we tackle politics, culture, and technology with incisive analysis. When the headlines change by the minute, you can count on us to cut through the noise and serve you clarity on a silver platter.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.